Ioannis Vlachos, Ph.D., is Assiciate Professor of Pathology, Harvard Medical School (HMS), and the Director of the Spatial Technologies Unit of the HMS Initiative for RNA Medicine. He also directs the Bioinformatics Unit of the Precision RNA Medicine Core. Ioannis is the co-Director of the Bioinformatics Program of the Cancer Research Institute (CRI), a Member of the Dana Farber / Harvard Cancer Center, and an Associate Member of the and an Associated Faculty of the Broad Institute of MIT & Harvard.
Dr. Vlachos’ research focuses on the optimal use of cutting-edge technologies for reverse translation, including bulk, single cell, and spatial tissue profiling to inform clinical decision making. To this end, his team is developing and applying novel technologies and AI/ML methodologies for data integration and target or biomarker prioritization. His group is creating the necessary data and methods to bring these novel approaches in precision medicine applications. To enable the community gain access and benefit from the spatial tissue profiling revolution, he established the Spatial Technologies Unit, with support from the Commonwealth of Massachusetts, Beth Israel Deaconess Medical Center, and the HMS Initiative for RNA Medicine.
Dr. Vlachos is working in rendering Spatial Tissue Profiling into a powerhouse for discovery, innovation, and clinical breakthroughs. His team in the Spatial Technologies Unit is transforming research-focused spatial technologies into robust, automated, and highly repeatable production-grade methods. In 2023 Dr. Vlachos co-founded the Global Alliance for Spatial Technologies (GESTALT, www.globalspatial.org), in an effort to bring together the spatial tissue profiling community and to support world-wide efforts for standards in the field.
Dr. Vlachos work is supported by funding from diverse sources, including the NIH, the DoD, foundations, and collaborations with the industry. 10 of his publications are within the 1% most cited as evaluated by ISI/Web of Science..